InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-11.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Mottola Frank, VP Senior. Director active across 1 company, notably Supernus Pharmaceuticals, INC.. Aggregated, 15 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €160k. History available since 16 February 2023. The latest transaction was disclosed on 19 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
5,000 shares@ US$39.4050.0% of flowCommon StockSEC:0001628280-25-058506
5,000 shares@ US$39.400.0059% mcap50.0% of flowCommon StockSEC:0001628280-25-058506:0
2,625 shares0Common StockSEC:0001628280-25-011325:0
337 shares@ US$33.051.6% of flowCommon StockSEC:0001628280-25-010472:0
2,010 shares0Common StockSEC:0001628280-25-008262:0
1,125 shares0Common StockSEC:0001628280-25-007528:0
15,000 shares@ US$9.1319.6% of flowCommon StockSEC:0001628280-24-046668:0
990 shares0Common StockSEC:0001104659-24-029434:0
1,875 shares0Common StockSEC:0001104659-24-028276:0
750 shares0Common StockSEC:0001104659-24-027571:0
2,000 shares@ US$9.242.6% of flowCommon StockSEC:0001104659-23-119162:0
750 shares0Common StockSEC:0001104659-23-044665:0
4,780 shares@ US$35.98824.6% of flowCommon StockSEC:0001104659-23-033366:0
750 shares0Common StockSEC:0001104659-23-025368:0
1,500 shares0Common StockSEC:0001104659-23-023877:0
15 of 15 declarations
About Mottola Frank
Mottola Frank serves as SVP, Chief Technical Operations Officer at SUPERNUS PHARMACEUTICALS, INC. In this role, he oversees the technical and strategic operations of the company. His expertise in operational management allows him to optimize performance and ensure product quality. Frank plays a crucial role in implementing growth and innovation strategies.
